SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: CuttingEdge Bio who wrote (3267)3/24/2021 8:27:36 PM
From: DewDiligence_on_SI  Read Replies (1) | Respond to of 3557
 
Do you believe the fact that [PFE’s phase-1 drug is] old and originally for SARS has important bearing on whether or not it will work for Covid?
It has some bearing, IMO. PFE’s drug may work for COVID (and other coronaviruses), but it probably won’t work for COVID as well as an antiviral designed from scratch to impede SARS-CoV-2, specifcally.